[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals, Inc. (REGN): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now",
    "summary": "We recently compiled a list of the 11 Oversold Blue Chip Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other oversold blue chip stocks. The uncertainty related to the tariff announcements continues to influence Wall Street. Reuters reported that […]",
    "url": "https://finnhub.io/api/news?id=e66ffbb18f38ae65a49626a631ca1d2a8322aefd5ba7daf729fda6b05a29e919",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741649368,
      "headline": "Regeneron Pharmaceuticals, Inc. (REGN): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now",
      "id": 133186691,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 11 Oversold Blue Chip Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other oversold blue chip stocks. The uncertainty related to the tariff announcements continues to influence Wall Street. Reuters reported that […]",
      "url": "https://finnhub.io/api/news?id=e66ffbb18f38ae65a49626a631ca1d2a8322aefd5ba7daf729fda6b05a29e919"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500 Gains and Losses Today: Index Tumbles as Economic Concerns Intensify",
    "summary": "The S&P 500 dropped 2.7% on Monday, March 10, as U.S. tariffs and government job cuts heightened economic uncertainty and provoked recession concerns.",
    "url": "https://finnhub.io/api/news?id=48a630c88df976b42e4116870838310f3361cc29286608c2addb5f7206222087",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741642380,
      "headline": "S&P 500 Gains and Losses Today: Index Tumbles as Economic Concerns Intensify",
      "id": 133186692,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "The S&P 500 dropped 2.7% on Monday, March 10, as U.S. tariffs and government job cuts heightened economic uncertainty and provoked recession concerns.",
      "url": "https://finnhub.io/api/news?id=48a630c88df976b42e4116870838310f3361cc29286608c2addb5f7206222087"
    }
  },
  {
    "ts": null,
    "headline": "REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm",
    "summary": "The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. for violations of §§10 and 20 of the...",
    "url": "https://finnhub.io/api/news?id=31c953d81e1c77528ccd384bfc81361b296a8f9b8f6b583f3ce2dec3723389a4",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741625163,
      "headline": "REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm",
      "id": 133127690,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. for violations of §§10 and 20 of the...",
      "url": "https://finnhub.io/api/news?id=31c953d81e1c77528ccd384bfc81361b296a8f9b8f6b583f3ce2dec3723389a4"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=b06f21ce9db301d9d630170506e5c039567919e9ca0be9236fa4c76e19edcc0c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741624920,
      "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 133155192,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=b06f21ce9db301d9d630170506e5c039567919e9ca0be9236fa4c76e19edcc0c"
    }
  },
  {
    "ts": null,
    "headline": "First Circuit Adopts But-For Causation Standard For Kickback-Premised False Claims Act Actions",
    "summary": "On 18 February 2025, the First Circuit Court of Appeals issued its decision in United States v. Regeneron Pharmaceuticals, Inc., determining that “but-for” causation is the proper standard for...",
    "url": "https://finnhub.io/api/news?id=895f85e1eee9318c1273d51f4433cdf21f5c5601e3ec8c213f9b6e2da9796a8b",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741601411,
      "headline": "First Circuit Adopts But-For Causation Standard For Kickback-Premised False Claims Act Actions",
      "id": 133117647,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "On 18 February 2025, the First Circuit Court of Appeals issued its decision in United States v. Regeneron Pharmaceuticals, Inc., determining that “but-for” causation is the proper standard for...",
      "url": "https://finnhub.io/api/news?id=895f85e1eee9318c1273d51f4433cdf21f5c5601e3ec8c213f9b6e2da9796a8b"
    }
  },
  {
    "ts": null,
    "headline": "REGN LAWSUIT ALERT: The Gross Law Firm Notifies Regeneron Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline",
    "summary": "NEW YORK, March 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Regeneron Pharmaceuticals, Inc. . ...",
    "url": "https://finnhub.io/api/news?id=bb6a3f1583ab6314c8e4dc3e551129438778f74db4e1cb792483957a48cd5f73",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741585582,
      "headline": "REGN LAWSUIT ALERT: The Gross Law Firm Notifies Regeneron Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline",
      "id": 133116200,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "NEW YORK, March 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Regeneron Pharmaceuticals, Inc. . ...",
      "url": "https://finnhub.io/api/news?id=bb6a3f1583ab6314c8e4dc3e551129438778f74db4e1cb792483957a48cd5f73"
    }
  }
]